Document is current
Any future updates will be listed below
-
Authors
Norlin, Stefan
Axelsson, Jan
Ericsson, Madelene
Edlund, Helena https://orcid.org/0000-0002-3553-7348
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (KAW 2015.0278)
Knut och Alice Wallenbergs Stiftelse (2019.0278)
- License Information
-
More Information
Article History
Received: 4 October 2022
Accepted: 18 August 2023
First Online: 25 August 2023
Competing interests
: H.E. is a cofounder, shareholder, and consultant of the unlisted biotech company Betagenon AB/Amplifier Therapeutics. J.A., S.N., and M.E. declare no competing interests.
